Ron Bentsur - Nov 25, 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
Nov 25, 2022
Transactions value $
$3,335
Form type
4
Date filed
11/29/2022, 03:31 PM
Previous filing
Nov 21, 2022
Next filing
Nov 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1.11K +150 +0% $7.38 3.02M Nov 25, 2022 Direct F1
transaction NVCT Common Stock Purchase $1.11K +150 +0% $7.40 3.02M Nov 28, 2022 Direct F1
transaction NVCT Common Stock Purchase $1.12K +150 +0% $7.45 3.02M Nov 29, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.